Literature DB >> 19628514

Intra-arterial transplantation of adult bone marrow cells restores blood flow and regenerates skeletal muscle in ischemic limbs.

Qi Liu1, Zhiqiang Chen, Toya Terry, Janice M McNatt, James T Willerson, Pierre Zoldhelyi.   

Abstract

OBJECTIVE: Bone marrow cell therapy promotes angiogenesis, but the cellular fate of bone marrow cells (BMCs) in the absence of immunosuppressant interventions is unclear. We created a model of severe hind limb ischemia to address whether BMCs form new blood vessels or differentiate into other tissues. METHODS AND
RESULTS: After ligating the common femoral artery in ApoE knockout mice, we injected either phosphate buffered saline (PBS) or 5 x 10(7) adult unfractionated BMCs obtained from green fluorescent protein-positive mice. Laser Doppler imaging of the ischemic limbs revealed that intra-arterial BMCs significantly increased blood flow recovery in ischemic limbs beginning 21 days after surgery and peaking at 27 days (61.8% +/- 15% vs. 41.9% +/- 13.9%, respectively, for BMCs and PBS, P < .05). The BMCs differentiated into small blood vessels, skeletal myofibers, and supporting membranes, and these changes were associated with increased serum levels of vascular endothelial growth factor (VEGF), fibroblast growth factor 2 (FGF-2), transforming growth factor beta (TGFbeta), interleukin 4 (IL-4), and tumor necrosis factor alpha (TNF-alpha).
CONCLUSIONS: Adult BMCs injected into ischemic limbs without immunosuppressant therapy differentiated into blood vessels and skeletal myofibers, and this was associated with accelerated blood flow restoration and increased serum levels of VEGF, FGF-2, TGF-beta, IL-4, and TNF-alpha. Skeletal muscle formation may provide benefits beyond angiogenesis to patients with chronic peripheral arterial disease or to patients with low cardiac output states who also suffer from skeletal muscle atrophy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19628514     DOI: 10.1177/1538574409335158

Source DB:  PubMed          Journal:  Vasc Endovascular Surg        ISSN: 1538-5744            Impact factor:   1.089


  10 in total

Review 1.  Skeletal Blood Flow in Bone Repair and Maintenance.

Authors:  Ryan E Tomlinson; Matthew J Silva
Journal:  Bone Res       Date:  2013-12-31       Impact factor: 13.567

2.  Molecular imaging of bone marrow mononuclear cell survival and homing in murine peripheral artery disease.

Authors:  Koen E A van der Bogt; Alwine A Hellingman; Maarten A Lijkwan; Ernst-Jan Bos; Margreet R de Vries; Juliaan R M van Rappard; Michael P Fischbein; Paul H Quax; Robert C Robbins; Jaap F Hamming; Joseph C Wu
Journal:  JACC Cardiovasc Imaging       Date:  2012-01

3.  Treatment of hind limb ischemia using angiogenic peptide nanofibers.

Authors:  Vivek A Kumar; Qi Liu; Navindee C Wickremasinghe; Siyu Shi; Toya T Cornwright; Yuxiao Deng; Alon Azares; Amanda N Moore; Amanda M Acevedo-Jake; Noel R Agudo; Su Pan; Darren G Woodside; Peter Vanderslice; James T Willerson; Richard A Dixon; Jeffrey D Hartgerink
Journal:  Biomaterials       Date:  2016-04-26       Impact factor: 12.479

4.  VEGFR endocytosis regulates the angiogenesis in a mouse model of hindlimb ischemia.

Authors:  Yingnan Bai; Rongle Liu; Zhixing Li; Yaqi Zhang; Xiaoyan Wang; Jian Wu; Zhuoquan Li; Sanli Qian; Bingyu Li; Zhenzhong Zhang; Abdel Hamid Fathy; Donato Cappetta; Jingmin Zhou; Yunzeng Zou; Juying Qian; Junbo Ge
Journal:  J Thorac Dis       Date:  2019-05       Impact factor: 2.895

5.  CD34⁺/M-cadherin⁺ bone marrow progenitor cells promote arteriogenesis in ischemic hindlimbs of ApoE⁻/⁻ mice.

Authors:  Toya Terry; Zhiqiang Chen; Richard A F Dixon; Peter Vanderslice; Pierre Zoldhelyi; James T Willerson; Qi Liu
Journal:  PLoS One       Date:  2011-06-03       Impact factor: 3.240

6.  Prostacyclin-producing human mesenchymal cells target H19 lncRNA to augment endogenous progenitor function in hindlimb ischaemia.

Authors:  Yuxiao Deng; Zhongwei Yang; Toya Terry; Su Pan; Darren G Woodside; Jingxiong Wang; Kehe Ruan; James T Willerson; Richard A F Dixon; Qi Liu
Journal:  Nat Commun       Date:  2016-04-15       Impact factor: 14.919

7.  Improving the therapeutic efficacy of mesenchymal stromal cells to restore perfusion in critical limb ischemia through pulsed focused ultrasound.

Authors:  Pamela A Tebebi; Saejeong J Kim; Rashida A Williams; Blerta Milo; Victor Frenkel; Scott R Burks; Joseph A Frank
Journal:  Sci Rep       Date:  2017-02-07       Impact factor: 4.379

Review 8.  Sarcopenia and peripheral arterial disease: a systematic review.

Authors:  Mégane Pizzimenti; Alain Meyer; Anne-Laure Charles; Margherita Giannini; Nabil Chakfé; Anne Lejay; Bernard Geny
Journal:  J Cachexia Sarcopenia Muscle       Date:  2020-07-10       Impact factor: 12.910

Review 9.  Current Status of Angiogenic Cell Therapy and Related Strategies Applied in Critical Limb Ischemia.

Authors:  Lucía Beltrán-Camacho; Marta Rojas-Torres; Mᵃ Carmen Durán-Ruiz
Journal:  Int J Mol Sci       Date:  2021-02-26       Impact factor: 5.923

Review 10.  Current Strategies for the Regeneration of Skeletal Muscle Tissue.

Authors:  Emine Alarcin; Ayca Bal-Öztürk; Hüseyin Avci; Hamed Ghorbanpoor; Fatma Dogan Guzel; Ali Akpek; Gözde Yesiltas; Tuba Canak-Ipek; Meltem Avci-Adali
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.